glp-1 microdosing perimenopause During Menopause: Is it Right for You? Microdosing GLP-1s: Benefits for Menopause

doi:10.1097/HC9.0000000000000352 5

Addressing Sagging Body Skin Another area GLP-1 users often notice changes

However, rapid pharmacologically induced weight loss may be accompanied by unfavorable body-composition changes, including reductions in lean mass, and weight regain is common following treatment discontinuation, underscoring a major durability gap

Whatever the reason, switching requires careful planning

Among the gut hormones, glucagon-like peptide 1 (GLP-1) is released in response to a meal from enteroendocrine cells, and GLP-1 receptors (GLP-1Rs) are found in both the periphery and the CNS

This is often temporary and resolves after the patch is removed